Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $178,032 | 109 | 70.0% |
| Travel and Lodging | $46,972 | 110 | 18.5% |
| Consulting Fee | $15,205 | 19 | 6.0% |
| Food and Beverage | $14,050 | 678 | 5.5% |
| Education | $46.88 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $225,461 | 372 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $14,426 | 31 | $0 (2018) |
| Allergan, Inc. | $5,482 | 36 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $950.05 | 37 | $0 (2024) |
| PFIZER INC. | $836.87 | 40 | $0 (2024) |
| Amarin Pharma Inc. | $542.24 | 33 | $0 (2022) |
| Esperion Therapeutics, Inc. | $499.21 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $497.66 | 29 | $0 (2022) |
| GlaxoSmithKline, LLC. | $481.86 | 27 | $0 (2024) |
| Novo Nordisk Inc | $481.67 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,659 | 56 | Amgen Inc. ($4,849) |
| 2023 | $46,552 | 92 | Amgen Inc. ($45,634) |
| 2022 | $28,530 | 107 | Amgen Inc. ($27,462) |
| 2021 | $67,683 | 174 | Amgen Inc. ($66,413) |
| 2020 | $8,083 | 75 | Amgen Inc. ($7,145) |
| 2019 | $16,539 | 99 | Amgen Inc. ($14,024) |
| 2018 | $36,316 | 155 | Amgen Inc. ($20,035) |
| 2017 | $44,942 | 162 | Amgen Inc. ($39,899) |
All Payment Transactions
920 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $10.56 | General |
| 12/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $10.19 | General |
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.83 | General |
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Cardio-renal | ||||||
| 09/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $96.66 | General |
| Category: Cardio-pulmonary | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 08/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Cardiovascular | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: Inflammation | ||||||
| 08/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,442 | 2,154 | $305,196 | $102,779 |
| 2022 | 22 | 1,261 | 2,083 | $278,095 | $92,040 |
| 2021 | 49 | 3,361 | 5,103 | $404,476 | $138,066 |
| 2020 | 49 | 4,992 | 8,233 | $582,694 | $189,925 |
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 478 | $108,984 | $41,253 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $25,480 | $11,631 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 86 | 91 | $27,846 | $10,743 | 38.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 84 | 85 | $10,965 | $6,219 | 56.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 88 | 88 | $23,320 | $5,087 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 55 | $10,780 | $3,567 | 33.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 70 | 70 | $15,750 | $3,158 | 20.1% |
| 92548 | Test for balance and posture | Office | 2023 | 90 | 90 | $26,100 | $3,108 | 11.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 124 | 333 | $6,660 | $2,789 | 41.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 91 | 95 | $10,450 | $2,655 | 25.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $5,005 | $1,994 | 39.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 81 | 81 | $4,617 | $1,895 | 41.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 43 | 44 | $7,700 | $1,529 | 19.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 87 | 87 | $3,393 | $1,462 | 43.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 83 | 83 | $3,237 | $1,394 | 43.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 100 | 114 | $5,700 | $1,181 | 20.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 41 | $3,034 | $1,171 | 38.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 39 | 40 | $2,000 | $874.38 | 43.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 23 | 28 | $1,596 | $663.32 | 41.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 28 | $2,072 | $292.32 | 14.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 93 | $279.00 | $69.42 | 24.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 19 | $228.00 | $41.80 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 467 | $106,476 | $40,185 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 93 | 119 | $36,414 | $13,435 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 54 | 54 | $14,040 | $6,649 | 47.4% |
About Dr. Mark Carlson, M.D
Dr. Mark Carlson, M.D is a Internal Medicine healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609837368.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Carlson, M.D has received a total of $254,305 in payments from pharmaceutical and medical device companies, with $5,659 received in 2024. These payments were reported across 920 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($178,032).
As a Medicare-enrolled provider, Carlson has provided services to 11,056 Medicare beneficiaries, totaling 17,573 services with total Medicare billing of $522,810. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Sioux City, IA
- Active Since 03/31/2006
- Last Updated 11/22/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609837368
Products in Payments
- Repatha (Biological) $142,319
- Otezla (Drug) $82,289
- DUZALLO (Drug) $14,390
- LINZESS (Drug) $4,968
- ELIQUIS (Drug) $593.34
- Vascepa (Drug) $542.24
- NEXLETOL (Drug) $499.21
- FARXIGA (Drug) $470.78
- VIBERZI (Drug) $421.72
- Aimovig (Biological) $417.49
- NATPARA (Drug) $375.00
- Kerendia (Drug) $348.91
- JARDIANCE (Drug) $316.08
- EVENITY (Biological) $264.72
- XARELTO (Drug) $230.09
- Tymlos (Biological) $223.12
- Veozah (Drug) $218.44
- BREZTRI (Drug) $214.10
- CONTRAVE (Drug) $213.56
- Zilretta (Drug) $204.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sioux City
Muaiad Kittaneh, M.d, M.D
Internal Medicine — Payments: $10,470
Dr. Jitendrakumar Gupta, M.d, M.D
Internal Medicine — Payments: $3,652
Jerold Erlandson, Md, MD
Internal Medicine — Payments: $3,294
Dr. Olusola Ogundipe, Md, MD
Internal Medicine — Payments: $884.44
Dr. Steven Feeney, M.d, M.D
Internal Medicine — Payments: $349.19
Dr. Chakravarthi Pureti
Internal Medicine — Payments: $282.22